Ajanta Pharma Ltd Quarterly Results

Gross Sales

1,186.64

1,144.92

1,054.08

1,105.15

1,028.44

Excise Duty

0

0

0

0

0

Net Sales

1,186.64

1,144.92

1,054.08

1,105.15

1,028.44

Other Operating Income

0

0

0

0

0

Other Income

19.48

26.47

35.5

13.59

21.33

Total Income

1,206.12

1,171.39

1,089.58

1,118.74

1,049.77

Total Expenditure

875.47

814.57

775.76

791.08

737.78

PBIDT

330.65

356.82

313.82

327.66

311.99

Interest

6.02

0.73

1.53

2.49

2.34

PBDT

324.63

356.09

312.29

325.17

309.65

Depreciation

34.39

33.97

34.25

34.26

33.71

Minority Interest Before NP

0

0

0

0

0

Tax

76.11

79.38

73.11

91.31

89.32

Deferred Tax

-2.35

-3.03

2.21

-10.43

-8.68

Reported Profit After Tax

216.48

245.77

202.72

210.03

195.3

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

216.48

245.77

202.72

210.03

195.3

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

216.48

245.77

202.72

210.03

195.3

EPS (Unit Curr.)

17.27

19.54

16.1

16.68

15.51

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

1,400

0

0

1,300

0

Equity

25.07

25.07

25.27

25.27

25.27

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

27.86

31.16

29.77

29.64

30.33

PBDTM(%)

27.35

31.1

29.62

29.42

30.1

PATM(%)

18.24

21.46

19.23

19

18.98